Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial

Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care

(2015) MARC DE HERT et al.   World Psychiatry

Impact of socioeconomic deprivation on rate and cause of death in severe mental illness

(2014) Julie Langan Martin et al.   BMC Psychiatry

Assessment and treatment of physical health problems among people with schizophrenia: national cross-sectional study

(2014) Mike J. Crawford et al.   BRITISH JOURNAL OF PSYCHIATRY

Metabolic Syndrome and Metabolic Abnormalities in Bipolar Disorder: A Meta-Analysis of Prevalence Rates and Moderators

(2013) Davy Vancampfort et al.   AMERICAN JOURNAL OF PSYCHIATRY

Improving physical health and reducing substance use in psychosis – randomised control trial (IMPACT RCT): study protocol for a cluster randomised controlled trial

(2013) Fiona Gaughran et al.   BMC Psychiatry

Provision of health promotion programmes to people with serious mental illness: a mapping exercise of four South London boroughs

(2013) C. O'Brien et al.   Journal of Psychiatric and Mental Health Nursing

Mortality in Schizophrenia: Clinical and Serological Predictors

(2013) Faith Dickerson et al.   SCHIZOPHRENIA BULLETIN

Racial patterns of cardiovascular disease risk factors in serious mental illness and the overall U.S. population

(2013) Tanya E. Keenan et al.   SCHIZOPHRENIA RESEARCH

A meta-analysis of cardio-metabolic abnormalities in drug naïve, first-episode and multi-episode patients with schizophrenia versus general population controls

(2013) Davy Vancampfort et al.   World Psychiatry

Cardiometabolic risk factors in people with psychotic disorders: The second Australian national survey of psychosis

(2012) Cherrie A Galletly et al.   AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY

A systematic review of correlates of physical activity in patients with schizophrenia

(2011) D. Vancampfort et al.   ACTA PSYCHIATRICA SCANDINAVICA

Psychopathology, coronary heart disease and metabolic syndrome in schizophrenia spectrum patients with deficit versus non-deficit schizophrenia: Findings from the CLAMORS study

(2011) Celso Arango et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Prevalence of Metabolic Syndrome in Patients with Psoriasis: A Population-Based Study in the United Kingdom

(2011) Sinéad M. Langan et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Prevalence of Metabolic Syndrome and Metabolic Abnormalities in Schizophrenia and Related Disorders—A Systematic Review and Meta-Analysis

(2011) Alex J. Mitchell et al.   SCHIZOPHRENIA BULLETIN

Smoking cessation in severe mental illness: what works?

(2010) Lindsay Banham et al.   ADDICTION

Twenty-five year mortality of a community cohort with schizophrenia

(2010) Steve Brown et al.   BRITISH JOURNAL OF PSYCHIATRY

Cardiovascular and metabolic risk in outpatients with schizoaffective disorder treated with antipsychotics: Results from the CLAMORS study

(2010) J. Bobes et al.   EUROPEAN PSYCHIATRY

Antipsychotics Associated with the Development of Type 2 Diabetes in Antipsychotic-Naïve Schizophrenia Patients

(2010) Jimmi Nielsen et al.   NEUROPSYCHOPHARMACOLOGY

Considering a frame of reference for physical activity research related to the cardiometabolic risk profile in schizophrenia

(2010) Davy Vancampfort et al.   PSYCHIATRY RESEARCH

Screening for the metabolic syndrome using simple anthropometric measurements in south Asian and white Europeans: A population-based screening study. The Leicester Ethnic Atherosclerosis and Diabetes Risk (LEADER) Study

(2010) Kamlesh Khunti et al.   Primary Care Diabetes

International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes

(2009)   DIABETES CARE

Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC)

(2009) M. De Hert et al.   EUROPEAN PSYCHIATRY

Excess heart-disease-related mortality in a national study of patients with mental disorders: identifying modifiable risk factors

(2009) Amy M. Kilbourne et al.   GENERAL HOSPITAL PSYCHIATRY

11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study)

(2009) Jari Tiihonen et al.   LANCET

Prevention of antipsychotic-induced weight gain with early behavioural intervention in first-episode psychosis: 2-year results of a randomized controlled trial

(2009) Mario Álvarez-Jiménez et al.   SCHIZOPHRENIA RESEARCH

Prevalence of diabetes and the metabolic syndrome in a sample of patients with bipolar disorder

(2008) Ruud van Winkel et al.   BIPOLAR DISORDERS

The prevalence of metabolic syndrome in patients with bipolar disorder

(2007) Maria P. Garcia-Portilla et al.   JOURNAL OF AFFECTIVE DISORDERS